Trials / Completed
CompletedNCT05999942
A Study to Investigate Lung Deposition of Inhaled Amikacin-loaded Liposomes in Healthy Male Participants
A Gamma Scintigraphy Study to Investigate the Lung Deposition of Inhaled Amikacin-Loaded Liposomes in Healthy Male Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- Insmed Incorporated · Industry
- Sex
- Male
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The primary purpose of this study is to determine the intra and extra pulmonary deposition and clearance of inhaled amikacin-loaded liposomes by gamma scintigraphy in healthy male participants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Liposomal Amikacin for Inhalation | Administered via the Pari LC STAR™ nebulizer. |
Timeline
- Start date
- 2004-06-02
- Primary completion
- 2004-06-29
- Completion
- 2004-06-29
- First posted
- 2023-08-21
- Last updated
- 2023-08-21
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05999942. Inclusion in this directory is not an endorsement.